View Item 

Show simple item record

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee
dc.contributor.authorKolasinski, Sharon L.
dc.contributor.authorNeogi, Tuhina
dc.contributor.authorHochberg, Marc C.
dc.contributor.authorOatis, Carol
dc.contributor.authorGuyatt, Gordon
dc.contributor.authorBlock, Joel
dc.contributor.authorCallahan, Leigh
dc.contributor.authorCopenhaver, Cindy
dc.contributor.authorDodge, Carole
dc.contributor.authorFelson, David
dc.contributor.authorGellar, Kathleen
dc.contributor.authorHarvey, William F.
dc.contributor.authorHawker, Gillian
dc.contributor.authorHerzig, Edward
dc.contributor.authorKwoh, C. Kent
dc.contributor.authorNelson, Amanda E.
dc.contributor.authorSamuels, Jonathan
dc.contributor.authorScanzello, Carla
dc.contributor.authorWhite, Daniel
dc.contributor.authorWise, Barton
dc.contributor.authorAltman, Roy D.
dc.contributor.authorDiRenzo, Dana
dc.contributor.authorFontanarosa, Joann
dc.contributor.authorGiradi, Gina
dc.contributor.authorIshimori, Mariko
dc.contributor.authorMisra, Devyani
dc.contributor.authorShah, Amit Aakash
dc.contributor.authorShmagel, Anna K.
dc.contributor.authorThoma, Louise M.
dc.contributor.authorTurgunbaev, Marat
dc.contributor.authorTurner, Amy S.
dc.contributor.authorReston, James
dc.date.accessioned2020-02-05T15:09:20Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2020-02-05T15:09:20Z
dc.date.issued2020-02
dc.identifier.citationKolasinski, Sharon L.; Neogi, Tuhina; Hochberg, Marc C.; Oatis, Carol; Guyatt, Gordon; Block, Joel; Callahan, Leigh; Copenhaver, Cindy; Dodge, Carole; Felson, David; Gellar, Kathleen; Harvey, William F.; Hawker, Gillian; Herzig, Edward; Kwoh, C. Kent; Nelson, Amanda E.; Samuels, Jonathan; Scanzello, Carla; White, Daniel; Wise, Barton; Altman, Roy D.; DiRenzo, Dana; Fontanarosa, Joann; Giradi, Gina; Ishimori, Mariko; Misra, Devyani; Shah, Amit Aakash; Shmagel, Anna K.; Thoma, Louise M.; Turgunbaev, Marat; Turner, Amy S.; Reston, James (2020). "2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee." Arthritis Care & Research 72(2): 149-162.
dc.identifier.issn2151-464X
dc.identifier.issn2151-4658
dc.identifier.urihttps://hdl.handle.net/2027.42/153772
dc.publisherWiley Periodicals, Inc.
dc.title2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelGeriatrics
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153772/1/acr24131.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/153772/2/acr24131_am.pdf
dc.identifier.doi10.1002/acr.24131
dc.identifier.sourceArthritis Care & Research
dc.identifier.citedreferenceNissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, et al, for the PRECISION Trial Investigators. Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis. N Engl J Med 2016; 375: 2519 – 29.
dc.identifier.citedreferenceCisternas MG, Murphy L, Sacks JJ, Solomon DH, Pasta DJ, Helmick CG. Alternative methods for defining osteoarthritis and the impact on estimating prevalence in a US population‐based survey. Arthritis Care Res (Hoboken) 2016; 68: 574 – 80.
dc.identifier.citedreferenceGBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability‐adjusted life‐years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: P1603 – 58.
dc.identifier.citedreferenceMurphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, et al. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum 2008; 59: 1207 – 13.
dc.identifier.citedreferenceMurphy LB, Helmick CG, Schwartz TA, Renner JB, Tudor G, Koch GG, et al. One in four people may develop symptomatic hip osteoarthritis in his or her lifetime. Osteoarthritis Cartilage 2010; 18: 1372 – 9.
dc.identifier.citedreferenceQin J, Barbour KE, Murphy LB, Nelson AE, Schwartz TA, Helmick CG, et al. Lifetime risk of symptomatic hand osteoarthritis: the Johnston County Osteoarthritis Project. Arthritis Rheumatol 2017; 69: 1204 – 12.
dc.identifier.citedreferenceGuyatt GH, Oxman AD, Vist GE, Kunz R, Falck‐Ytter Y, Alonso‐Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924 – 6.
dc.identifier.citedreferenceHochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012; 64: 465 – 74.
dc.identifier.citedreferenceDobson F, Hinman RS, Hall M, Marshall CJ, Sayer T, Anderson C, et al. Reliability and measurement error of the Osteoarthritis Research Society International (OARSI) recommended performance‐based tests of physical function in people with hip and knee osteoarthritis. Osteoarthritis Cartilage 2017; 25: 1792 – 6.
dc.identifier.citedreferenceJuhl C, Lund H, Roos EM, Zhang W, Christensen R. A hierarchy of patient‐reported outcomes for meta‐analysis of knee osteoarthritis trials: empirical evidence from a survey of high impact journals [review]. Arthritis 2012; 2012: 136245.
dc.identifier.citedreferenceGuyatt GH, Oxman AD, Kunz R, Falck‐Ytter Y, Vist GE, Liberati A, et al, for the GRADE Working Group. Going from evidence to recommendations. BMJ 2008; 336: 1049 – 51.
dc.identifier.citedreferenceGuyatt GH, Oxman AD, Kunz R, Vist GE, Falck‐Ytter Y, Schünemann HJ, for the GRADE Working Group. What is “quality of evidence” and why is it important to clinicians? BMJ 2008; 336: 995 – 8.
dc.identifier.citedreferenceAlonso‐Coello P, Schünemann HJ, Moberg J, Brignardello‐Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1. Introduction. BMJ 2016; 353: i2016.
dc.identifier.citedreferenceNeumann I, Santesso N, Akl EA, Rind DM, Vandvik PO, Alonso‐Coello P, et al. A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach. J Clin Epidemiol 2016; 72: 45 – 55.
dc.identifier.citedreferenceAndrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck‐Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013; 66: 719 – 25.
dc.identifier.citedreferenceAndrews JC, Schünemann HJ, Oxman AD, Pottie K, Meerpohl JJ, Coello PA, et al. GRADE guidelines: 15. Going from evidence to recommendation—determinants of a recommendation’s direction and strength. J Clin Epidemiol 2013; 66: 726 – 35.
dc.identifier.citedreferenceElwyn G, Frosch D, Thomson R, Joseph‐Williams N, Lloyd A, Kinnersley P, et al. Shared decision making: a model for clinical practice. J Gen Intern Med 2012; 27: 1361 – 7.
dc.identifier.citedreferenceSkelly AC, Chou R, Dettori JR, Turner JA, Friedly JL, Rundell SD, et al, for the Agency for Healthcare Research and Quality. Noninvasive nonpharmacological treatment for chronic pain: a systematic review. 2018. URL: https://effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharma-chronic-pain-cer-209.pdf.
dc.identifier.citedreferenceMessier SP, Resnik AE, Beavers DP, Mihalko SL, Miller GD, Nicklas BJ, et al. Intentional weight loss in overweight and obese patients with knee osteoarthritis: is more better? Arthritis Care Res (Hoboken) 2018; 70: 1569 – 75.
dc.identifier.citedreferenceBernardy K, Klose P, Welsch P, Häuser W. Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome: a systematic review and meta‐analysis of randomized controlled trials. Eur J Pain 2018; 22: 242 – 60.
dc.identifier.citedreferenceHajihasani A, Rouhani M, Salavati M, Hedayati R, Kahlaee AH. The influence of cognitive behavioral therapy on pain, quality of life, and depression in patients receiving physical therapy for chronic low back pain: a systematic review. PM R 2019; 11: 167 – 76.
dc.identifier.citedreferenceIsmail A, Moore C, Alshishani N, Yaseen K, Alshehri MA. Cognitive behavioural therapy and pain coping skills training for osteoarthritis knee pain management: a systematic review. J Phys Ther Sci 2017; 29: 2228 – 35.
dc.identifier.citedreferenceEberly L, Richter D, Comerci G, Ocksrider J, Mercer D, Mlady G, et al. Psychosocial and demographic factors influencing pain scores of patients with knee osteoarthritis. PLoS One 2018; 13: e0195075.
dc.identifier.citedreferencePerlman AI, Ali A, Njike VY, Hom D, Davidi A, Gould‐Fogerite S, et al. Massage therapy for osteoarthritis of the knee: a randomized dose‐finding trial. PLoS One 2012; 7: e30248.
dc.identifier.citedreferenceRannou F, Pelletier JP, Martel‐Pelletier J. Efficacy and safety of topical NSAIDs in the management of osteoarthritis: evidence from real‐life setting trials and surveys. Semin Arthritis Rheum 2016; 45 Suppl: S18 – 21.
dc.identifier.citedreferenceChan FK, Ching JY, Tse YK, Lam K, Wong GL, Ng SC, et al. Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry‐independent, double‐blind, double‐dummy, randomised trial. Lancet 2017; 389: 2375 – 82.
dc.identifier.citedreferenceSolomon DH, Husni ME, Libby PA, Yeomans ND, Lincoff AM, Lüscher TF, et al. The risk of major NSAID toxicity with celecoxib, ibuprofen, or naproxen: a secondary analysis of the PRECISION trial. Am J Med 2017; 130: 1415 – 22.
dc.identifier.citedreferenceMcAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, et al. Effect of intra‐articular triamcinolone vs saline on knee cartilage volume and pain in patients with knee osteoarthritis: a randomized clinical trial. JAMA 2017; 317: 1967 – 75.
dc.identifier.citedreferenceDa Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, Juni P, et al. Effectiveness of non‐steroidal anti‐inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta‐analysis. Lancet 2017; 390: e21 – 33.
dc.identifier.citedreferenceBusse JW, Wang L, Kamaleldin M, Craigie S, Riva JJ, Montoya L, et al. Opioids for chronic noncancer pain: a systematic review and meta‐analysis. JAMA 2018; 320: 2448 – 60.
dc.identifier.citedreferenceClarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl Health Stat Report 2015; 1 – 16.
dc.identifier.citedreferenceOng JS, Gharahkhani P, An J, Law MH, Whiteman DC, Neale RE, et al. Vitamin D and overall cancer risk and cancer mortality: a Mendelian randomization study. Hum Mol Genet 2018; 27: 4315 – 22.
dc.identifier.citedreferencePilz S, Verheyen N, Grübler MR, Tomaschitz A, März W. Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol 2016; 13: 404 – 17.
dc.identifier.citedreferenceRunhaar J, Rozendaal RM, van Middelkoop M, Bijlsma HJ, Doherty M, Dziedzic KS, et al. Subgroup analyses of the effectiveness of oral glucosamine for knee and hip osteoarthritis: a systematic review and individual patient data meta‐analysis from the OA trial bank. Ann Rheum Dis 2017; 76: 1862 – 9.
dc.identifier.citedreferenceWandel S, Jüni P, Tendal B, Nüesch E, Villiger PM, Welton NJ, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta‐analysis. BMJ 2010; 341: c4675.
dc.identifier.citedreferenceBiggee BA, Blinn CM, Nuite M, Silbert JE, McAlindon TE. Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis. Ann Rheum Dis 2007; 66: 260 – 2.
dc.identifier.citedreferenceRutjes AW, Jüni P, da Costa BR, Trelle S, Nüesch E, Reichenbach S. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta‐analysis. Ann Intern Med 2011; 157: 180 – 91.
dc.identifier.citedreferenceZhang W, Doherty M. Efficacy paradox and proportional contextual effect (PCE). Clin Immunol 2018; 186: 82 – 6.
dc.identifier.citedreferenceRubin R. Limits on opioid prescribing leave patients with chronic pain vulnerable. JAMA 2019; 321: 2059 – 62.
dc.identifier.citedreferenceZeng C, Dubreuil M, LaRochelle MR, Lu N, Wei J, Choi HK, et al. Association of tramadol with all‐cause mortality among patients with osteoarthritis. JAMA 2019; 321: 969 – 82.
dc.identifier.citedreferenceLeopoldino AO, Machado GC, Ferreira PH, Pinheiro MB, Day R, McLachlan AJ, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev 2019; 2: CD013273.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
acr24131.pdf
Size:
700.7KB
Format:
PDF
View/Open
Name:
acr24131_am.pdf
Size:
361.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.